long intergenic non-protein coding RNA 2642Genealiases: []
Q-omics provides the consensus-scored LINC02642 profile across patient tissues and cancer cell-line models. LINC02642 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in SKCM. Among the 18 cancer types available for tumor–normal comparison, LINC02642 is differentially expressed in 9, with the highest sampling consensus in KIRC. Additionally, LINC02642 RNA expression shows 12,651 significant protein co-abundance associations, with the highest sampling consensus in LSCC. Together, these results highlight SKCM, KIRC, and LSCC as cancer lineages where LINC02642 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02642 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02642 survival associations across molecular data types. LINC02642 RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02642 RNA expression–survival associations across cancer types. High LINC02642 expression shows unfavorable associations in KIRP and KIRC, but favorable associations in SKCM, UCEC, PAAD and LUAD. The SKCM Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify SKCM as the clearest survival context for LINC02642 RNA expression.
This table summarizes LINC02642 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 9. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02642. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02642 shows lower tumor expression in COAD and higher tumor expression in KIRC, KIRP, LIHC, HNSC and ESCA. The KIRC box plot shows higher LINC02642 RNA expression in tumor versus normal tissue (log2 FC = +0.387, t-test p < 0.001).
This table shows molecular features associated with LINC02642 in patient tissues and cancer cell lines. In patient samples, LINC02642 shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set.
